$6.5-Billion ‘Baby Powder-Cancer’ Settlement Proposal Pushed Forward by Johnson and Johnson | Facts Matter
Headquartered in New Jersey, Johnson and Johnson is one of the largest pharmaceutical companies in the world. It’s also one of the handful of companies that made a windfall during the pandemic with their vaccine. In fact, the Janssen shot was making the company upwards of $740 million dollar per quarter—that was, of course, before the shot was pulled off the market due to an elevated risk of serious blood clots in vaccine recipients. However, having their vaccine pulled off the market might be the least of Johnson and Johnson’s financial worries. That’s because just yesterday, the company…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.